BrainSpark Health in Plymouth Meeting offers a new route for opioid addiction

By

Plymouth Meeting-based BrainSpark Health is helping people fight addiction using a new treatment that accelerates and improves the detoxification process. (Photo courtesy of BrainSpark.)
A new Montgomery County treatment center, which is taking an unconventional treatment approach, has joined the increasingly crowded field of facilities for people with opioid addiction problems.
BrainSpark in Plymouth Meeting is offering patients with drug and alcohol addictions NAD IV therapy.
“Technically, it’s a rebooting of your brain,” said Dr. Franco Picofazzi, a dental surgeon and anesthesiologist who co-founded BrainSpark with Philadelphia technology entrepreneur Richard Masterson, writes John George in the Philadelphia Business Journal.
[uam_ad id=”54865″]

Looking to diversify his medical practice, Picofazzi learned about how some clinics were using NAD IV therapy to treat addiction. After visiting several centers offering the therapy, he decided to open BrainSpark with Masterson, whom he has known for the past two decades.
“This has the potential to save lives,” said Masterson, the former co-founder and chairman of Audience Partners who is now the chief digital strategist for Altice USA. “All of us are touched by stories of addiction.”
BrainSpark is based in a small medical office building owned by Picofazzi, near the Plymouth Meeting Mall, on Germantown Pike.
BrainSpark is billing itself as the first NAD IV Therapy center in the Philadelphia region.
Nationally, there are about 25 centers — most in the western part of the country — offering the treatment.
NAD IV therapy is not inexpensive.
The cost is about $1,000 a day for an IV therapy session that can last six to eight hours. Because the treatment is not FDA approved, it is not covered by insurance.
To read the complete story click here.
[uam_ad id=”54875″]

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

Hidden
MT Yes
This field is for validation purposes and should be left unchanged.
Advertisement